GemPharmatech Balance Sheet Health
Financial Health criteria checks 6/6
GemPharmatech has a total shareholder equity of CN¥2.1B and total debt of CN¥85.2M, which brings its debt-to-equity ratio to 4%. Its total assets and total liabilities are CN¥2.6B and CN¥428.2M respectively. GemPharmatech's EBIT is CN¥105.8M making its interest coverage ratio -3.7. It has cash and short-term investments of CN¥1.2B.
Key information
4.0%
Debt to equity ratio
CN¥85.15m
Debt
Interest coverage ratio | -3.7x |
Cash | CN¥1.25b |
Equity | CN¥2.13b |
Total liabilities | CN¥428.20m |
Total assets | CN¥2.56b |
Financial Position Analysis
Short Term Liabilities: 688046's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥340.8M).
Long Term Liabilities: 688046's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥87.4M).
Debt to Equity History and Analysis
Debt Level: 688046 has more cash than its total debt.
Reducing Debt: 688046's debt to equity ratio has reduced from 5.4% to 4% over the past 5 years.
Debt Coverage: 688046's debt is well covered by operating cash flow (91.7%).
Interest Coverage: 688046 earns more interest than it pays, so coverage of interest payments is not a concern.